All News #Library
Biotech
SNS812 siRNA COVID Drug Chosen for ATS 2025 Talk
16 May 2025 //
PR NEWSWIRE
Pan-COVID New Drug - SNS812 Achieves Superiority in Phase 2 Study
10 Sep 2024 //
PR NEWSWIRE

Market Place
Sourcing Support